Digital adherence technologies in tuberculosis
- PMID: 37591581
- DOI: 10.1016/S2214-109X(23)00308-X
Digital adherence technologies in tuberculosis
Conflict of interest statement
This Correspondence was an outcome of a short-term scientific mission in the University Medical Center Groningen (University of Groningen, Groningen, Netherlands) in April, 2023. GH has received a grant from COST Action CA19132 ENABLE, supported by the European Cooperation in Science and Technology (COST). JFMvB has received grants and consultancy fees, paid to his insitution, from multiple manufacturers of digital adherence technologies but that are unrelated to this Correspondence.
Comment on
-
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.Lancet Glob Health. 2023 May;11(5):e693-e703. doi: 10.1016/S2214-109X(23)00068-2. Lancet Glob Health. 2023. PMID: 37061308 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical